IMMP Q1 2026 Earnings EPS Misses Estimates as Development Progress Continues PAVS Q2 2022 Earnings Massive EPS Miss Highlights Operational Challenges Jade Biosciences Inc JBIO Q1 2026 Earnings EPS Miss Amid Continued PreRevenue Phase Catalyst Bancorp Inc Q3 2025 Earnings Modest Profitability Amid Stable Operations ADC Therapeutics Q1 2026 Earnings EPS Beat but No Revenue Reported Stock Slips NICE Q1 2026 Earnings EPS Beat Amid Mixed Market Sentiment Milestone Pharmaceuticals Q1 2026 Earnings ClinicalStage Biotech Reports Wider Loss Than Expected Silgan Holdings Q1 2026 Earnings EPS Beats Estimates Amid Focus on Cost Management Immunome Inc IMNM Q1 2026 Earnings NarrowerThanExpected Loss Fails to Lift Sentiment Costamare Bulkers Holdings Limited CMDB Q1 2026 Earnings Positive Earnings Per Share Amid Slight Market Headwinds CLDI Q4 2025 Earnings Smallerthanexpected loss highlights progress in clinicalstage biotherapeutics HUYA Q1 2026 Earnings Strong EPS Beat Highlights Operational Efficiency Amid Revenue Disclosures